Description

([5-(1-Ethyl-1H-Pyrazol-3-Yl)-4-(Tetrahydrofuran-2-Ylmethyl)-4H-1,2,4-Triazol-3-Yl]Thio)Acetic Acid is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound matters because it serves as a critical building block for developing new therapeutic agents, particularly in areas requiring complex heterocyclic chemistry. It is primarily needed by research institutions and pharmaceutical companies engaged in medicinal chemistry, process development, and the production of innovative drug candidates targeting a range of diseases.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those with triazole and pyrazole pharmacophores.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies for new therapeutic targets.
• Process Chemistry Development: Serves as a standard or starting material for scaling up API synthesis under GMP conditions.
• Agrochemical Research: Potential application in the development of new fungicides or herbicides due to its heterocyclic structure.
• Chemical Biology Probes: Can be utilized to create tool compounds for studying biological pathways and target validation.
• Custom Synthesis: Employed by contract research and manufacturing organizations (CROs/CMOs) for client-specific molecule assembly.

Basic Information

Product Name	([5-(1-Ethyl-1H-Pyrazol-3-Yl)-4-(Tetrahydrofuran-2-Ylmethyl)-4H-1,2,4-Triazol-3-Yl]Thio)Acetic Acid
CAS No.	1005592-03-9
Molecular Formula	C15H20N6O3S
Molecular Weight	364.42 g/mol
Synonyms	2-[[5-(1-Ethylpyrazol-3-yl)-4-(tetrahydrofuran-2-ylmethyl)-1,2,4-triazol-3-yl]thio]acetic acid; (5-(1-Ethyl-1H-pyrazol-3-yl)-4-[(tetrahydrofuran-2-yl)methyl]-4H-1,2,4-triazol-3-yl)sulfanylacetic acid; 1005592-03-9; 2-({5-[1-Ethyl-1H-pyrazol-3-yl]-4-[(oxolan-2-yl)methyl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetic acid
EINECS	Contact for details

Quality Control

Our ([5-(1-Ethyl-1H-Pyrazol-3-Yl)-4-(Tetrahydrofuran-2-Ylmethyl)-4H-1,2,4-Triazol-3-Yl]Thio)Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical R&D and pre-clinical development. Certificates of Analysis (COA) detailing purity, assay, and impurity profiles are provided with every shipment and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed to minimize exposure to atmospheric humidity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 97.0%
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.